Non-desensitized positive chronotropic effect of anti-angiotension II receptor autoantibodies in a patient with malignant hypertension
(abstract)
ML Fu H Herlitz G Wallukat E Hilme T Hedner J Hoebeke A Hjalmarson 1996 Non-desensitized positive chronotropic effect of anti-angiotension II receptor autoantibodies in a patient with malignant hypertension (abstract Circulation 94 4046a
Patients with preeclampsia develop agonistic antibodies against the angiotension AT1 receptor
G Wallukat V Homuth T Fischer C Lindschau B Horstkamp A Jüpner E Baur E Nissen K Vetter D Neichel JW Dudenhausen H Haller FC Luft 1999 Patients with preeclampsia develop agonistic antibodies against the angiotension AT1 receptor J Clin Invest 103 945-952
Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide
Fu ML, Leung PS, Wallukat G, Bergstrom G, Fu H, Schulze W, Herlitz H (1999) Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 8:317-324
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension
ML Fu H Herlitz W Schulze G Wallukat P Micke P Eftekhari KG Sjogren A Hjalmarson W Muller-Esterl J Hoebeke 2000 Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension J Hypertens 18 945-953
Changes in autoantibodies against cardiovascular AT1-receptor during development of renovascular hypertension in rats
JM Zhi LY Zhao XY Jiao RR Zhao 2002 Changes in autoantibodies against cardiovascular AT1-receptor during development of renovascular hypertension in rats Sheng Li Xue Bao 54 317-320
Expermental study of At1-receptor peptide induced myocardial immune damage in rats
YS Luo YH Liao M Wang YM Wei JH Dong JP Wang YP Lu 2001 Expermental study of At1-receptor peptide induced myocardial immune damage in rats J Tongji Med Univ 21 202-204
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
M Rhian L Schiffrin Touyz and Ernesto 2000 Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells Hypertension 52 639-672
The structural factor in hypertension, with special emphasis in the altered geometric design of the systemic
JH Laragh BM Brenner (eds) Raven Press New York
B Folkow 1995 The structural factor in hypertension, with special emphasis in the altered geometric design of the systemic. In: JH Laragh BM Brenner (eds) Hypertension: Physiology, diagnosis, and management Raven Press New York 31